Apoptosis in displaced temporomandibular joint disc with and without reduction: An immunohistochemical study

Journal of Oral Pathology and Medicine

Volumn 40, Issue 1, 2011, Pages 103-110

  Loreto, Carla ^a   Almeida, Luis Eduardo ^b   Trevilatto, Paula ^b   Leonardi, Rosalia ^a  

^a UNIVERSITY OF CATANIA   (Italy)

^b Center for Health and Biological Sciences   (Brazil)

Author keywords

Caspase 3; Internal derangement; Temporomandibular joint disc

Indexed keywords

CASPASE 3; VITAMIN;

ADULT; APOPTOSIS; ARTICLE; CADAVER; CELL DEATH; CHIROPRACTIC; CLINICAL ARTICLE; CONSERVATIVE TREATMENT; CONTROLLED STUDY; DIET SUPPLEMENTATION; ENZYME ACTIVITY; FEMALE; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MANIPULATIVE MEDICINE; NUCLEAR MAGNETIC RESONANCE IMAGING; PHYSIOTHERAPY; PRIORITY JOURNAL; SPLINT; TEMPOROMANDIBULAR JOINT; TEMPOROMANDIBULAR JOINT DISORDER;

ADULT; APOPTOSIS; CASE-CONTROL STUDIES; CASPASE 3; DISLOCATIONS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; TEMPOROMANDIBULAR JOINT DISK; TEMPOROMANDIBULAR JOINT DISORDERS; YOUNG ADULT;

EID: 78650780212     PISSN: 09042512     EISSN: 16000714     Source Type: Journal    
DOI: 10.1111/j.1600-0714.2010.00920.x     Document Type: Article

References (72)

1. Pérez del Palomar A, Doblaré M. An accurate simulation model of anteriorly displaced TMJ discs with and without reduction. Med Eng Phys 2007; 29: 216-26.
2. Okeson JP Management of temporomandibular disorders and occlusion. St Louis: Mosby-Year book, Inc, 1993; 294, 409, 477.
3. Eberhard D, Bantleon HP, Steger W. Functional magnetic resonance imaging of temporomandibular joint disorders. Eur J Orthod 2000; 22: 489-97.
4. Nitzan DW. The process of lubrication impairment and its involvement in temporomandibular joint disc displacement: a theoretical concept. J Oral Maxillofac Surg 2001; 59: 36-45.
5. Wilkes CH. Structural and functional alterations of the temporomandibular joint. Northwest Dent 1978; 57: 287-94.
6. Detamore MS, Athanasiou KA. Structure and function of the temporomandibular joint disc: implications for tissue engineering. J Oral Maxillofac Surg 2003; 61: 494-506.
7. Pankov R, Yamada KM. Fibronectin at a glance. J Cell Sci 2002; 115: 3861-3.
8. Scapino RP. Histopathology associated with malposition of the human temporomandibular joint disc. Oral Surg Oral Med Oral Pathol 1983; 55: 382-97.
9. Hall MB, Brown RW, Baughman RA. Histologic appearance of the bilaminar zone in internal derangement of the temporomandibular joint. Oral Surg Oral Med Oral Pathol 1984; 58: 375-81.
10. Isacsson G, Isberg A, Johansson AS, Larson O. Internal derangement of the temporomandibular joint: radiographic and histologic changes associated with severe pain. J Oral Maxillofac Surg 1986; 44: 771-8.
11. McCoy JM, Gotcher JE, Chase DC. Histologic grading of TMJ tissues in internal derangement. Cranio 1986; 4: 213-18.
12. Kurita K, Westesson PL, Sternby NH, et al. Histologic features of the temporomandibular joint disk and posterior disk attachment: comparison of symptom-free persons with normally positioned disks and patients with internal derangement. Oral Surg Oral Med Oral Pathol 1989; 67: 635-43.
13. Westesson PL, Bronstein SL, Liedberg J. Internal derangement of the temporomandibular joint: morphologic description with correlation to joint function. Oral Surg Oral Med Oral Pathol 1985; 59: 323-31.
14. Leonardi R, Loreto C, Barbato E, Polimeri A, Caltabiano R, Lo Muzio L. A histochemical survey of the human temporomandibular joint disc of patients with internal derangement without reduction. J Craniofac Surg 2007; 18: 1429-33.
15. Loreto C, Musumeci G, Leonardi R. Chondrocyte-like apoptosis in temporomandibular joint disc internal derangement as a repair-limiting mechanism. An in vivo study. Histol Histopathol 2009; 24: 293-8.
16. Orhan K, Nishiyama H, Tadashi S, Murakami S, Furukawa S. Comparison of altered signal intensity, position, and morphology of the TMJ disc in MR images corrected for variations in surface coil sensitivity. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2006; 101: 515-22.
17. Taşkaya-Yilmaz N, Oǧütcen-Toller M. Magnetic resonance imaging evaluation of temporomandibular joint disc deformities in relation to type of disc displacement. J Oral Maxillofac Surg 2001; 59: 860-5.
18. Milam SB. Pathophysiology and epidemiology of TMJ. J Musculoskelet Neuronal Interact 2003; 3: 382-90.
19. Zardeneta G, Milam SB, Schmitz JP. Iron-dependent generation of free radicals: plausible mechanisms in the progressive deterioration of the temporomandibular joint. J Oral Maxillofac Surg 2000; 58: 302-8.
20. Carlsson GE, Oberg T, Bergman F, Fajers CM. Morphological changes in the mandibular joint disk in temporomandibular joint pain dysfunction syndrome. Acta Odontol Scand 1967; 25: 163-81.
21. Castelli WA, Nasjleti CE, Diaz-Perez R, Caffesse RG. Histopathologic findings in temporomandibular joints of aged individuals. J Prosthet Dent 1985; 53: 415-19.
22. Helmy ES, Timmis DP, Sharawy MH, Abdelatif O, Bays RA. Fatty change in the human temporomandibular joint disc. Light and electron microscopy study. Int J Oral Maxillofac Surg 1990; 19: 38-43.
23. De Bont LGM, Stengenga B. Pathology of temporomandibular joint internal derangement and osteoarthrosis. Int J Oral Maxillofac Surg 1993; 22: 71-4.
24. Marchetti C, Piacentini C, Farina A, Bernasconi G, Calligaro A. A microscopic and immunocytochemical study of structural changes in dysfunctional human temporomandibular joint discs. Arch Oral Biol 1995; 40: 549-57.
25. Milam SB, Zardeneta G, Schmitz JP. Oxidative stress and degenerative temporomandibular joint disease: a proposed hypothesis. J Oral Maxillofac Surg 1998; 56: 214-23.
26. Jibiki M, Shimoda S, Nakagawa Y, Kawasaki K, Asada K, Ishibashi K. Calcifications of the disc of the temporomandibular joint. J Oral Pathol Med 1999; 28: 413-19.
27. Matsuda S, Mishima K, Yoshimura Y, Hatta T, Otani H. Apoptosis in the development of the temporomandibular joint. Anat Embryol 1997; 196: 383-91.
28. Nagai H, Kumamoto H, Fukuda M, Takahashi T. Inducible nitric oxide synthase and apoptosis-related factors in the synovial tissues of temporomandibular joints with internal derangement and osteoarthritis. J Oral Maxillofac Surg 2003; 61: 801-7.
29. Spears R, Oakes R, Bellinger LL, Hutchins B. Tumour necrosis factor-alpha and apoptosis in the rat temporomandibular joint. Arch Oral Biol 2003; 48: 825-34.
30. Huang Q, Singh B, Sharawy M. Immunohistochemical analysis of Bcl-2 and Bax oncoproteins in rabbit craniomandibular joint. Arch Oral Biol 2004; 49: 143-8.
31. Gu Z, Shibata T, Cao Z, Feng J, Hu J. Chondrocyte apoptosis in temporomandibular joints with disc displacement. J Oral Maxillofac Surg 2002; 60: 1026-31.
32. Kim HA, Lee YJ, Seong SH, Choe KW. Apoptotic chondrocyte death in human osteoarthritis. J Rheumatol 2000; 27: 455-62.
33. Blanco FJ, Guitian R, Vazquez-Martul E, de Toro, FJ Galdo F. Osteoarthritis chondrocytes die by apoptosis. A possible pathway for osteoarthritis pathology. Arthritis Rheum 1998; 41: 284-9.
34. Charriaut-Marlangue C, Ben-Ari Y. A cautionary note on the use of the TUNEL stain to determine apoptosis. Neuroreport 1995; 7: 61-4.
35. Adams JM, Cory S. The Bcl-2 protein family: arbiters of cell survival. Science 1998; 281: 1322-6.
36. Ferri KF, Kroemer G. Organelle-specific initiation of cell death pathways. Nat Cell Biol 2001; 3: 255-63.
37. Green DR, Reed JC. Mitochondria and apoptosis. Science 1998; 281: 1309-12.
38. Scaffidi C, Schmitz I, Zha J, Korsmeyer SJ, Krammer PH, Peter ME. Differential modulation of apoptosis sensitivity in CD95 type I and type II cells. J Biol Chem 1999; 274: 22532-8.
39. Krammer PH. CD95(APO-1/Fas)-mediated apoptosis: live and let die. Adv Immunol 1999; 71: 163-210.
40. Park JB, Lee JK, Park SJ, Kim KW, Riew KD. Mitochondrial involvement in fas-mediated apoptosis of human lumbar disc cells. J Bone Joint Surg Am 2005; 87: 1338-42.
41. Dimitroulis G. The role of surgery in the management of disorders of the temporomandibular joint: a critical review of the literature. Part 2. Int J Oral Maxillofac Surg 2005; 34: 231-7.
42. Dolwick MF. Temporomandibular joint surgery for internal derangement. Dent Clin North Am 2007; 51: 195208.
43. Miloro M, Henriksen B Discectomy as the primary surgical option for internal derangement of the temporomandibular joint. J Oral Maxillofac Surg 2010; 68: 782-9.
44. Touré G, Duboucher C, Vacher C. Anatomical modifications of the temporomandibular joint during ageing. Surg Radiol Anat 2005; 27: 51-5.
45. Kopp S. Clinical findings in temporomandibular joint osteoarthrosis. Scand J Dent Res 1977; 85: 434-43.
46. Luder HU. Factors affecting degeneration in human temporomandibular joints as assessed histologically. Eur J Oral Sci 2002; 110: 106-13.
47. Shafer DM, Assael L, White LB, Rossomando EF. Tumor necrosis factor-α as a biochemical marker of pain and outcome in temporomandibular joint with internal derangement. J Oral Maxillofac Surg 1994; 52: 786-91.
48. Kubota E, Kubota T, Matsumoto J, Shibata T, Muratami KI. Synovial fluid cytokines and proteinases as markers of temporomandibular joint disease. J Oral Maxillofac Surg 1998; 56: 192-8.
49. Kaneyama K, Segami N, Nishimura M, Suzuki T, Sato J. Importance of proinflammatory cytokines in synovial fluid from 121 joints with temporomandibular disorders. Br J Oral Maxillofac Surg 2002; 40: 418-23.
50. Nishimura M, Segami N, Kaneyama K, Sato J, Fujimura K. Comparison of cytokine level in synovial fluid between successful and unsuccessful cases in arthrocentesis of the temporomandibular joint. J Oral Maxillofac 2004; 62: 284-7.
51. Kardel R, Ulfgren AK, Reinholt P, Holmlund A. Inflammatory cell and cytokine patterns in patients with painful clicking and osteoarthritis in temporomandibular joint. Int J Oral Maxillofac Surg 2003; 32: 390-6.
52. Suzuki T, Segami N, Nishimura M, Nojima T. Co-expression of interleukin-1β and tumor necrosis factor α in synovial tissues and synovial fluids of temporomandibular joint with internal derangement: comparison with histological grading of synovial inflammation. J Oral Pathol Med 2002; 31: 549-57.
53. Creagh EM, Conroy H, Martin SJ. Caspase-activation pathways in apoptosis and immunity. Immunol Rev 2003; 193: 10-21.
54. Moncada S, Palmer RM, Higgs EA. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev 1991; 43: 109-42.
55. Schmidt HH, Walter U. NO at work. Cell 1994; 78: 919-25.
56. Brockhaus F, Brüne B. p53 accumulation in apoptotic macrophages is an energy demanding process that precedes cytochrome c release in response to nitric oxide. Oncogene 1999; 18: 6403-10.
57. Brüne B, Von Knethen A, Sandau KB. Nitric oxide (NO): an effector of apoptosis. Cell Death Differ 1999; 6: 969-75.
58. Blanco FJ, Ochs RI, Schwarz H, Lotz M. Chondrocyte apoptosis induced by nitric oxide. Am J Pathol 1995; 146: 75-85.
59. Hashimoto S, Takahashi K, Amiel D, Coutts RD, Lotz M. Chondrocyte apoptosis and nitric oxide production during experimentally induced osteoarthritis. Arthritis Rheum 1998; 41: 1266-74.
60. Erickson GF. Defining apoptosis: players and systems. J Soc Gynecol Invest 1997; 4: 219-28.
61. Huppertz B, Kaufmann HGFP. The apoptosis cascade-morphological and immunohistochemical methods for its visualization. Anat Embryol 1999; 200: 1-18.
62. Sukedai M, Fukuda J. Involvement of tumor necrosis factor-alpha and interleukin-8 in antigen induced arthritis of the rabbit temporomandibular joint. J Oral Pathol Med 2004; 33: 102-10.
63. Imirzalioǧlu P, Uçkan S, Güler N, Haberal A, Uçkan D. Synovial apoptosis in temporomandibular joint disc displacement without reduction. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2009; 108: 693-8.
64. Tschoeke SK, Hellmuth M, Hostmann A, et al. Apoptosis of human intervertebral discs after trauma compares to degenerated discs involving both receptor-mediated and mitochondrial-dependent pathways. J Orthop Res 2008; 26: 999-1006.
65. Gruber HE, Hanley EN. Analysis of aging and degeneration of the human intervertebral disc. Comparison of surgical specimens with normal controls. Spine 1998; 23: 751-7.
66. Park JB, Chang H, Kim KW. Expression of Fas ligand and apoptosis of disc cells in herniated lumbar disc tissue. Spine 2001; 6: 618-21.
67. Ward C, Dransfield I, Chilvers ER, Haslett C, Rossi AG. Pharmacological manipulation of granulocyte apoptosis: potential therapeutic targets. Trends Pharmacol Sci 1999; 20: 503-9.
68. Rannou F, Lee TS, Zhou RH, et al. Intervertebral disc degeneration: the role of the mitochondrial pathway in annulus fibrosus cell apoptosis induced by overload. Am J Pathol 2004; 164: 915-24.
69. Haschtmann D, Stoyanov JV, Gédet P, Ferguson SJ. Vertebral endplate trauma induces disc cell apoptosis and promotes organ degeneration in vitro. Eur Spine J 2008; 17: 289-99.
70. Leonardi R, Almeida LE, Trevilatto PC, Loreto C. Occurence and regional distribution of TRAIL and DR5 on temporomandibular joint discs: comparison of disc derangement with and without reduction. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2010; 109: 244-51.
71. Ariga K, Miyamoto S, Nakase T, et al. The relationship between apoptosis of endplate chondrocytes and aging and degeneration of the intervertebral disc. Spine 2001; 15: 2414-20.
72. Lotz JC, Chin JR. Intervertebral disc cell death is dependent on the magnitudeand duration of spinal loading. Spine 2000; 25: 1477-83.